Method and apparatus for delivering an additive with a cpap machine

ABSTRACT

The present invention is a method and apparatus for delivering an additive with a continuous positive airway pressure (“CPAP”) machine. The invention includes mixing an additive with humidifier water and providing the additive to the patient with the CPAP machine. According to certain embodiments, the additive can be an aromatic additive or a therapeutic additive.

CROSS-REFERENCE TO RELATED APPLICATION(S)

This application claims priority to U.S. Provisional Application No.60/532,926, filed on Dec. 29, 2003, which is hereby incorporated hereinby reference in its entirety.

TECHNICAL FIELD

The present invention relates to treatments for Sleep Apnea. Morespecifically, the present invention relates to an improved CPAP machineand methods of using a CPAP machine to provide an aromatic ortherapeutic additive in the air flow provided to the patient.

BACKGROUND OF THE INVENTION

Approximately twenty million people in the United States have beendiagnosed with Sleep Apnea. Sleep Apnea is an over-relaxation of thesoft tissue in the back of the throat that causes a cessation ofbreathing during sleep states. The breathing cessation can cause a lackof oxygen that results in drowsiness and sleep disorders during wakinghours.

One treatment for Sleep Apnea is a continuous positive airway pressure(“CPAP”) machine, which provides a continuous flow of air through thenostrils via a mask. The flow of air works to maintain an open airway.Sleep Apnea sufferers must wear the mask for the entire night. Onecommon component of a CPAP machine is a humidifier. Prior to applyingthe flow of air to the patient, the air is passed through the humidifierto add moisture to the air, thus helping to prevent the patient's nasalpassages from drying out.

One disadvantage of existing CPAP machines is that the moist air that isprovided to the patient is often stale or even has an unpleasant smellor taste. A further disadvantage is that the existing machines providenothing more than moist air to the patient.

There is a need in the art for a CPAP machine that provides a pleasanttasting or smelling flow of air to the patient. There is a further needfor a CPAP machine that is capable of providing more than just moistair.

BRIEF SUMMARY OF THE INVENTION

The present invention, in one embodiment, is a method of deliveringadditive with a continuous positive airway pressure (“CPAP”) machine.The method includes mixing an additive with humidifier water andproviding the additive to the patient with the CPAP machine. Accordingto an alternative embodiment, the additive can be an aromatic additiveor a therapeutic additive.

The present invention, in another embodiment, is an apparatus fordelivering an additive to a continuous positive airway pressure (“CPAP”)machine. The apparatus includes an additive delivery device associatedwith a reservoir of the CPAP machine. According to one embodiment, theapparatus also includes a flow control device associated with thedelivery device and configured to control delivery of the additive tothe CPAP machine.

In a further embodiment, the present invention is a packaged formulationfor delivering an additive in a continuous positive airway pressure(“CPAP”) machine. The formulation includes an additive and instructionsfor use of the additive with the CPAP machine. According to oneembodiment, the additive is an aromatic additive or a therapeuticadditive.

While multiple embodiments are disclosed, still other embodiments of thepresent invention will become apparent to those skilled in the art fromthe following detailed description, which shows and describesillustrative embodiments of the invention. As will be realized, theinvention is capable of modifications in various obvious aspects, allwithout departing from the spirit and scope of the present invention.Accordingly, the drawings and detailed description are to be regarded asillustrative in nature and not restrictive.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a schematic diagram of a CPAP machine, according to oneembodiment of the present invention.

FIG. 2 is a schematic diagram of a CPAP machine, according to analternative embodiment of the present invention.

DETAILED DESCRIPTION

The present invention relates to an improved CPAP machine and a methodof providing air flow to a patient having an aromatic or therapeuticadditive. The aromatic additive provides a pleasant aroma to the airflow delivered to the patient, thus eliminating any unpleasant smell ortaste associated with the air delivered by the CPAP machine. Further,the therapeutic additive allows the patient to receive treatment notonly for Sleep Apnea, but also for any other illness that can be treatedby inhalation of an appropriate substance.

FIG. 1 depicts a CPAP machine 50 according to one embodiment of thepresent invention. The machine 50 has a flow generator 52, a reservoir56, and a mask 18. The delivery component 14 has an inlet port 26 and ametering component 62. A tube 54 connects the flow generator 52 to thereservoir 56, and a tube 60 connects the reservoir 56 to the mask 62.

According to one embodiment, the flow generator 52 is configured tocreate an air flow that is provided to the reservoir 56 and then themask 62 via the tubes 54, 60. The flow generator 52 can be any knownflow generator for a CPAP machine.

In accordance with one aspect of the invention, the additive is added tothe reservoir 56 through the inlet port 58. According to one embodiment,a metering component 64 is configured to deliver the additive over timeto the reservoir 56 at a metered or regulated rate. That is, themetering component 64 is configured to regulate or control over time theamount of additive that is delivered to the reservoir 56. In one aspectof the invention, the metering component 64 is a metering dial similarto the device used to control intravenous injection flow rates. That is,the additive is placed into a flow line that passes through the dial andis regulated by turning the dial to pinch or open the line, therebyregulating the amount of additive that can pass through.

Alternatively, the metering component 64 is a ball-valve system, inwhich a canal that allows flow of the additive can be blocked by a ballin the canal. The ball is configured to have at least one hole in it,and the ball can be turned by use of a handle connected to the ball.When the ball is turned so that the hole creates a passage in the canal,flow of the additive through the canal occurs. When the ball is turnedso that the canal is completely blocked, flow of the additive isblocked. Further, the amount of flow can be regulated by regulating thesize of the passage by controlling how much the ball is turned in thecanal. Further, this device can be turned to provide various sizedholes, thus allowing the additive to flow through to the reservoir 56 ata controlled rate. In a further alternative, any known system for timedmetering or regulation of the flow of a fluid can be used with thepresent invention. In yet another alternative, the additive is delivereddirectly to the reservoir 56 without any metering or flow regulation.

The reservoir 56, in accordance with one embodiment, is configured tohold water and receive into the water the additive delivered through theinlet port 58. Thus, the reservoir 56 is configured to allow the mixingof the additive into the water. Air flow passes through the reservoir 56from the flow generator 52 to the mask 62. The reservoir 56 isconfigured to allow the air flow to take up moisture in the form of thewater and additive (be “humidified” with the water and additive) andfurther allow that air flow to pass out of the reservoir 56 and to themask 62. The reservoir 56 can be any known reservoir used with CPAPmachines to humidify air flow.

The mask 62 is configured to be placed on the patient's face and deliverthe humidified air flow with the additive to the patient in such afashion as to prevent Sleep Apnea. The mask 62 can be any known mask foruse with CPAP machines to deliver the air flow to the patient.

In use, according to one embodiment of the present invention, anaromatic additive is added to the inlet port 58. The additive is inconcentrate form. Alternatively, the additive is in pre-mixed form. In afurther alternative, the additive is in any form capable of being addedto the CPAP machine.

The aromatic additive, in accordance with one aspect of the invention,is a fragrance. The additive can be chosen from, but is not limited to,any of the following aromatic additives, including lilac, evergreen,menthol, jasmine, eucalyptus, floral, lemon, lime, orange, tangerine,peppermint, strawberry, cherry, anise, honey, mint, vanilla, mocha.Alternatively, the aromatic additive is any known pleasant fragrancethat can make the air flow more pleasant for the patient.

The air flow is generated by the flow generator 52 and provided to thereservoir 56. The aromatic additive is added to the reservoir 56. Theadditive is delivered in a timed metering fashion or by any other methodof flow regulation. Alternatively, the additive is delivered withoutflow regulation. The rate of delivery or the amount of the additive willvary depending on the additive and the size of the reservoir. As the airflow passes through the reservoir 56, the air is “humidified.” That is,a portion of the water and aromatic additive is taken up by the air andis delivered as a humidified air flow to the mask 62.

According to an alternative embodiment of the present invention, atherapeutic additive is added to the reservoir 56. The additive is inconcentrate form. Alternatively, the additive is in pre-mixed form. In afurther alternative, the additive is in any form capable of being addedto the CPAP machine.

The therapeutic additive, in accordance with one aspect of theinvention, is any substance with therapeutic effect that can beadministered by inhalation. The additive can be chosen from, but is notlimited to, any substance that treats any of the following ailments orillnesses, including sinus ailments, throat ailments, chest ailments,headaches, allergies, flu, cold, menstrual cramps, and insomnia.Further, the additive can be chosen from, but is not limited to, any ofthe following therapeutic substances, including antihistamines,decongestants, anti-inflammatories, anti-depressants, vitamins, glucose,and chloraseptics. Alternatively, the therapeutic additive is any knownsubstance having therapeutic effects that can be administered to thepatient by inhalation.

Several exemplary therapeutic additives, which shall not be consideredlimiting, include such respiratory-related, flu-related, andcold-related medications as products sold under brand names such asRobitussin®, Vicks®, TheraFlu®, Sudafed®, Contact®, Comtrex®, ZICAM®,Alka Seltzer®, Advil®, and Aleve®. Non-limiting exemplary additives forallergy relief, including some prescription medications, include certainproducts sold under brand names such as Chlor-Trimetor®, Advil®,Benadryl®, Claritin-D®, Claritin®, Allegra®, Nasacort®, Nasanex®, andZyrtec®. Non-limiting exemplary additives for pain relief, includingsome prescription medications, include certain products sold under brandnames such as Tylenol®, Motrin®, Advil®, Excedrin®, Aleve®, Celebrex®,Vioxx®, Flextra-DS®, Fioricet®, and Tramadol®. Non-limiting exemplaryadditives for menstrual relief include certain products sold under thebrand name Pamprin®. Non-limiting exemplary additives for women'shealth, including some prescription medications, include certainproducts sold under such brand names as Ortho Tri-Cyclen®, Nordette 28®,Triphasil®, Diflucan®, and Estradiol®. Non-limiting exemplary sleep aidadditives, including some prescription medications, include certainproducts sold under such brand names as Unisom®, Ambier®, and Sonata®.Non-limiting exemplary additives for arthritic relief include certainproducts sold under the brand name Tylenol®. Non-limiting exemplaryvitamin additives include all known vitamins such as A, B-12, C, E, etc.Non-limiting exemplary vitamin additives include certain products soldunder such brand names as Centrum®, Rexall®, Sundown®, Nature Made®,Natures Valley®, and Swanson Health®. Non-limiting exemplary additivesfor relief from viruses and/or infections, including some prescriptionmedications, include such products as penicillin and amoxicillin.Non-limiting exemplary muscle-relaxant additives, including someprescription medications, include products sold under such brand namesas Skelaxin®, Soma®, Flexeril®, and Zanflex®. Non-limiting exemplaryadditives for anxiety or depression, including some prescriptionmedications, include products under such brand names as Buspar®, Paxil®,Prozac®, Zoloft®, Wellbutrin®, and Celexa®. Non-limiting exemplary skincare additives, including some prescription medications, includeproducts such as retin A and products under such brand names as Renova®.Non-limiting exemplary additives for sexual or genital health, includingsome prescription medications, include products under such brand namesas Acyclovir® and Valtrex®. Non-limiting exemplary smoke-cessationadditives, including some prescription medications, include productsunder the brand name Zyban®.

The air flow is generated by the flow generator 52 and provided to thereservoir 56. The therapeutic additive is added to the reservoir 56. Theadditive is delivered in a timed metering fashion or by any other methodof flow regulation. Alternatively, the additive is delivered withoutflow regulation. The rate of delivery or the amount of the additive willvary depending on the prescribed application of the additive and thesize of the reservoir. As the air flow passes through the reservoir 56,the air is “humidified.” That is, a portion of the water and therapeuticadditive is taken up by the air and is delivered as a humidified airflow to the mask 62.

In accordance with one alternative aspect of the invention, any aromaticor therapeutic additive disclosed herein can be added to the reservoirof any existing CPAP machine. The additive is provided in pre-mixedform. Alternatively, the additive is provided in concentrate form. In afurther alternative, the additive is in any form capable of being addedto the reservoir of any existing CPAP machine.

FIG. 2 depicts a CPAP machine 10 according to an alternative embodimentof the present invention. The machine 10 has a flow generator 12, adelivery component 14, a reservoir 16, and a mask 18. The deliverycomponent 14 has an inlet port 26 and a metering component 28. A tube 20connects the flow generator 12 to the delivery component 14, while atube 22 connects the delivery component 14 to the reservoir 16, and atube 24 connects the reservoir 16 to the mask 18.

According to one embodiment, the flow generator 12 is configured tocreate an air flow that is provided through the delivery component 14 tothe reservoir 16 and then the mask 18 via the tubes 20, 22, 24.

The delivery component 14, according to one embodiment, is configured toreceive an additive and deliver the additive to the reservoir 16. Thedelivery component 14 is connected to the flow generator 12 by the tube20 and receives air flow from the generator 12 through the tube. Inaccordance with one aspect of the invention, the additive is added tothe delivery component 14 through the inlet port 26. The additive isthen mixed with the air flow and delivered to the reservoir 16 throughthe tube 22. Alternatively, the additive is delivered through the tube22 to the reservoir 16 separately from the air flow.

The delivery component 14, according to one embodiment, is configured todeliver the additive over time to the reservoir 16 at a metered orregulated rate using the metering component 28. That is, the meteringcomponent 28 is configured to regulate or control over time the amountof additive that is delivered to the reservoir 16. In one aspect of theinvention, the metering component 28 is a metering dial similar to thedevice used to control intravenous injection flow rates, as discussedabove. Alternatively, the metering component 28 is a ball-valve system,as discussed above. In a further alternative, any known system for timedmetering or regulation of the flow of a fluid can be used with thepresent invention. In yet another alternative, the additive is delivereddirectly to the reservoir 16 without any metering or flow regulation.

The reservoir 16, in accordance with one embodiment, is configured asdisclosed above. The reservoir 16 can be any known reservoir used withCPAP machines to humidify air flow.

The mask 18, according to one aspect of the invention, is configured asdescribed above. The mask 18 can be any known mask for use with CPAPmachines to deliver the air flow to the patient.

In use, according to one embodiment of the present invention, anaromatic additive as described above is added to the delivery component14. The air flow is generated by the generator 12 and provided to thedelivery component 14 and then to the reservoir 16. The aromaticadditive is added to the delivery component 14 and then delivered to thereservoir 16. The additive is delivered in a timed metering fashion orwithout flow regulation. The rate of delivery or the amount of theadditive will vary depending on the additive and the size of thereservoir. As the air flow passes through the reservoir 16, the air is“humidified.” That is, a portion of the water and aromatic additive istaken up by the air and is delivered as a humidified air flow to themask 18.

According to an alternative embodiment of the present invention, atherapeutic additive as described above is added to the deliverycomponent 14. The air flow is generated by the generator 12 and providedto the delivery component 14 and then to the reservoir 16. Thetherapeutic additive is added to the delivery component 14 and thendelivered to the reservoir 16. The additive is delivered in a timedmetering fashion or by any other method of flow regulation.Alternatively, the additive is delivered without flow regulation. Therate of delivery or the amount of the additive will vary depending onthe prescribed application of the additive and the size of thereservoir. As the air flow passes through the reservoir 16, the air is“humidified.” That is, a portion of the water and therapeutic additiveis taken up by the air and is delivered as a humidified air flow to themask 18.

Although the present invention has been described with reference topreferred embodiments, persons skilled in the art will recognize thatchanges may be made in form and detail without departing from the spiritand scope of the invention.

1-16. (canceled)
 17. A method of delivering additive with a continuouspositive airway pressure (“CPAP”) machine comprising: mixing an additivewith humidifier water using an additive delivery device; and providingthe additive to the patient with the CPAP machine, wherein a portion ofthe water and additive are taken up by the air in the CPAP machine anddelivered as a humidified air flow to a CPAP machine mask.
 18. Themethod of claim 17 wherein the additive is an aromatic additive.
 19. Themethod of claim 17 wherein the additive is a therapeutic additive. 20.An additive delivery apparatus for delivering an additive to a fluidreservoir of a continuous positive airway pressure (“CPAP”) machinecomprising: an additive delivery device configured to be arranged on thefluid reservoir, the additive delivery device comprising: an additiveinlet port configured to be coupled to the fluid reservoir in an areabetween an air flow inlet and air flow outlet of the CPAP machine, theadditive inlet port for introducing the additive to the fluid reservoir;and a flow control device configured to be in fluid communication withthe additive inlet port, the flow control device for controllingdelivery of the additive to the CPAP machine.
 21. The apparatus of claim20 wherein the flow control device is a metering dial.
 22. The apparatusof claim 20 wherein the flow control device is a ball-valve system. 23.The apparatus of claim 20 wherein the additive is an aromatic additive.24. The apparatus of claim 20 wherein the additive is a therapeuticadditive.
 25. An apparatus for delivering an additive to a continuouspositive airway pressure (“CPAP”) machine comprising: a reservoirconfigured with an air flow inlet and an air flow outlet; an additivedelivery component associated with the reservoir, the delivery componentcomprising: an additive inlet port arranged at the air flow inlet; and ametering component in fluid communication with the inlet port themetering component configured to meter the additive to the fluid in thefluid reservoir.
 26. The apparatus of claim 25 wherein the additive isan aromatic additive.
 27. The apparatus of claim 25 wherein the additiveis a therapeutic additive.
 28. The apparatus of claim 25 wherein themetering component is a metering dial.
 29. The apparatus of claim 25wherein the metering component is a ball-valve system.
 30. The apparatusof claim 25 wherein the delivery component is integral with thereservoir.
 31. The apparatus of claim 25 wherein the delivery componentis operably coupled with the reservoir by a tube.